ICE vs INM · P/E 37, rev $7.28B vs rev $4.9M
Intercontinental Exchange Inc (ICE) versus InMed Pharmaceuticals Inc (INM) — a side-by-side from cached financials, not a winner call.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ICE revenue for 2026-06-30 was $7.28B. Net income was $2.37B. Revenue was up 98.5% from 2026-03-31 to 2026-06-30. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. INM currently screens at market cap $5.2M.
ICE currently screens at market cap $103.55B and trailing P/E 37.3. INM currently screens at market cap $5.2M.
Not investment advice. Open the ICE and INM stock pages for the full models.
Not investment advice.